GDF7 Antikörper (AA 362-410) (Alexa Fluor 555)

Produktnummer ABIN1391411

Produktdetails anti-GDF7 Antikörper (Alexa Fluor 555)

Target: GDF7 (Growth Differentiation Factor 7 (GDF7))

Bindungsspezifität: AA 362-410

Reaktivität: Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser GDF7 Antikörper ist konjugiert mit Alexa Fluor 555

Applikation: Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))

Kreuzreaktivität: Ratte

Homologie: Human,Mouse,Cow,Pig,Horse,Chicken

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human GDF7

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Haltbarkeit: 12 months

Details zu GDF7

Target: GDF7 (Growth Differentiation Factor 7 (GDF7))

Andere Bezeichnung: GDF7 (GDF7 Produkte)

Synonyme: bmp12 antikoerper, gdf-7 antikoerper, gdf16 antikoerper, gdf16-A antikoerper, BMP12 antikoerper, GDF6/7 antikoerper, growth differentiation factor 7 S homeolog antikoerper, growth differentiation factor 7 antikoerper, gdf7.S antikoerper, GDF7 antikoerper, Gdf7 antikoerper

Hintergrund:

Synonyms: bmp12, bone morphogenetic protein 12, GDF-7, Gdf 7, GDF7_HUMAN, growth dferentiation factor 7, Growth/dferentiation factor 7.

Background: Growth/differentiation factors (GDFs) are members of the TGF superfamily (1,2). Members of the TGF superfamily are involved in embryonic development and adult tissue homeostasis (1). GDF-1 expression is almost exclusively restricted to the central nervous system and mediates cell differentiation events during embryonic development (3). Neither GDF-3 (Vgr-2) nor GDF-9 contains the conserved cysteine residue which is found in most other TGF superfamily members. GDF-3 is detectable in bone marrow, spleen, thymus and adipose tissue, whereas GDF-9 has only been detected in ovary (4). GDF-5 (also designated CDMP-1) has been shown to induce activation of plasminogen activator, thereby inducing angiogenesis. It is predominantly expressed in long bones during fetal embryonic development and is involved in bone formation. (5). GDF-5 mutations have been identified in mice with the mutation brachypodism (bp), a mutation which affects the length and number of bones in limbs (6). GDF-6 and GDF-7 are closely related to GDF-5 (6). GDF-8 has been shown to be a negative regulator of skeletal muscle mass (1).

Pathways: Tube Formation